La Riviere, France

Romain Vives

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2009.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Romain Vives: Innovator in Anti-HIV Research

Introduction

Romain Vives is a notable inventor based in La Riviere, France. He has made significant contributions to the field of medical research, particularly in the development of anti-HIV compositions. His innovative work aims to provide new avenues for the treatment of AIDS.

Latest Patents

Romain Vives holds a patent for an "Anti-HIV composition, production method thereof and medicament." This invention relates to a composition that includes a polyanion and a molecule capable of inducing the exposure of the CD4i epitope of the gp120 viral protein. The polyanion can be selected from substances such as heparin or heparan sulphate. The composition is intended for use in producing medicinal products aimed at treating AIDS. He has 1 patent to his name.

Career Highlights

Throughout his career, Romain Vives has worked with prominent organizations such as the Commissariat à l'Énergie Atomique and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Romain has collaborated with notable colleagues, including Quentin Sattentau and Claudio Vita. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Romain Vives is a dedicated inventor whose work in anti-HIV research has the potential to make a significant difference in the treatment of AIDS. His innovative compositions and methods reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…